Home › Funders › United States › Federal agency

National Institutes of Health

National Institutes of Health offers the programs listed below, some with dated deadlines still ahead. It sits within Department of Health and Human Services.

Type: Federal agency
Country: United States
Region: United States (national)
Sectors: Research and science Health and life sciences Nonprofits and charities Education and training Employment and workforce
Typical award: $927 to $27,999,994 per award (median published maximum: $500,000 to $1 million)
From the programs that publish per-award amounts.
Website: Not listed in our sources
Public contact: Public organizational contacts on file Unlock full profile / Sign up
Sources: SAM.gov Assistance Listings; Grants.gov XML extract; Federal Register agencies API (Federal Register profile)

Contact details are Pro

Pro shows the public organizational contacts listed in official sources (program office addresses and role mailboxes; we never store personal names or direct lines), plus CSV export. Paid plans are not on sale yet.

Unlock full profile / Sign up

Upcoming deadlines

2 November 2026 · Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
2 November 2026 · Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
5 November 2026 · Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
6 November 2026 · Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
6 November 2026 · Limited Competition for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)
9 November 2026 · Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
9 November 2026 · Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
10 November 2026 · Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
10 November 2026 · Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
10 November 2026 · Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
10 November 2026 · Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
10 November 2026 · Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)

See all deadlines in the calendar

Programs from this funder

21st Century Cures Act - Precision Medicine Initiative (Assistance Listing 93.368) United States (federal) · Dates vary
21st Century Cures Act: Regenerative Medicine Initiative - Research Projects (Assistance Listing 93.CRP) United States (federal) · Dates vary
A Holistic Approach to Study Non-Addictive Natural Products for Pain Management United States (federal) · Forecast
Academic Career Excellence (ACE) Award (K32 Independent Clinical Trial Not Allowed) United States (federal) · Closes 12 July 2029
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) United States (federal) · Closes 7 January 2028
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) United States (federal) · Closes 7 January 2027
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) United States (federal) · Closes 7 January 2027
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed) United States (federal) · Closes 7 January 2028
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) United States (federal) · Closes 7 January 2028
Accelerating Access to Critical Therapies for Amyotrophic Lateral Sclerosis Act (Assistance Listing 93.ALS) United States (federal) · Dates vary
Accelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed) United States (federal) · Closes 1 March 2027
Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) United States (federal) · Closes 11 February 2027
Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional) United States (federal) · Closes 7 January 2027
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed) United States (federal) · Closes 3 December 2027
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional) United States (federal) · Closes 30 November 2028
Advanced Development and Sustainment of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) United States (federal) · Forecast
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) United States (federal) · Recurring, next intake TBA
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) United States (federal) · Recurring, next intake TBA
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed) United States (federal) · Closes 10 November 2026
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) United States (federal) · Recurring, next intake TBA
Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers United States (federal) · Forecast
ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H) (Assistance Listing 93.384) United States (federal) · Dates vary
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) United States (federal) · Recurring, next intake TBA
Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed) United States (federal) · Closes 7 September 2027
Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional) United States (federal) · Closes 5 March 2029
Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed) United States (federal) · Recurring, next intake TBA
Advancing Genomic Medicine Research (R21 Clinical Trial Optional) United States (federal) · Recurring, next intake TBA
Advancing Healthcare for Older Adults from Populations that Experience Health Disparities (R01 - Clinical Trial Optional) United States (federal) · Closes 7 January 2028
Advancing HIV/AIDS Research within the Mission of the NIDCD (R01 Clinical Trial Optional) United States (federal) · Recurring, next intake TBA
Advancing Real-World Effectiveness Evidence for Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) United States (federal) · Forecast
Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00 - Clinical Trial Not Allowed) United States (federal) · Recurring, next intake TBA
Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed) United States (federal) · Recurring, next intake TBA
Advancing Screening, Diagnosis, and Referral for Late Talking Children United States (federal) · Forecast
Aging Research (Assistance Listing 93.866) United States (federal) · Dates vary
Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed) United States (federal) · Recurring, next intake TBA
AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) United States (federal) · Forecast
Alcohol Health Services Research (R34 Clinical Trial Optional) United States (federal) · Recurring, next intake TBA
Alcohol Research Programs - Other Research (Assistance Listing 93.AA5) United States (federal) · Dates vary
Alcohol Research Programs - Research Centers (Assistance Listing 93.AA6) United States (federal) · Dates vary
Alcohol Research Programs - Research Projects (Assistance Listing 93.AA1) United States (federal) · Dates vary
Alcohol Research Programs - SBIR/STTR (Assistance Listing 93.AA2) United States (federal) · Dates vary
Alcohol Research Programs - Training, Individual (Assistance Listing 93.AA3) United States (federal) · Dates vary
Alcohol Research Programs - Training, Institutional (Assistance Listing 93.AA4) United States (federal) · Dates vary
Alcohol Research Programs (Assistance Listing 93.273) United States (federal) · Dates vary
Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required) United States (federal) · Recurring, next intake TBA
All of Us Research Program (Assistance Listing 93.ALL) United States (federal) · Dates vary
Allergy and Infectious Diseases Research (Assistance Listing 93.855) United States (federal) · Dates vary
Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials United States (federal) · Forecast
Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required) United States (federal) · Recurring, next intake TBA
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional) United States (federal) · Closes 5 November 2027
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required) United States (federal) · Closes 10 November 2026
Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional) United States (federal) · Recurring, next intake TBA
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional) United States (federal) · Recurring, next intake TBA
ancient DNA for Modern Genomics (aDMG) Coordination Center United States (federal) · Forecast
ancient DNA for Modern Genomics (aDMG) Data Generation and Resource Center United States (federal) · Forecast
ancient DNA for Modern Genomics (aDMG) Research Projects (U01 Clinical Trials Not Allowed) United States (federal) · Forecast
Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) United States (federal) · Recurring, next intake TBA
Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed) United States (federal) · Forecast
Animal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed) United States (federal) · Closes 26 September 2028
Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed) United States (federal) · Recurring, next intake TBA
Arthritis, Musculoskeletal and Skin Diseases Research - Other Research (OR) (Assistance Listing 93.AR6) United States (federal) · Dates vary
Arthritis, Musculoskeletal and Skin Diseases Research - Research Centers (RC) (Assistance Listing 93.AR5) United States (federal) · Dates vary
Arthritis, Musculoskeletal and Skin Diseases Research - Research Projects (Assistance Listing 93.AR1) United States (federal) · Dates vary
Arthritis, Musculoskeletal and Skin Diseases Research - Training Individual (TR) (Assistance Listing 93.AR3) United States (federal) · Dates vary
Arthritis, Musculoskeletal and Skin Diseases Research - Training Institutional (TI) (Assistance Listing 93.AR4) United States (federal) · Dates vary
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) United States (federal) · Recurring, next intake TBA
Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed) United States (federal) · Recurring, next intake TBA
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed) United States (federal) · Forecast
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed) United States (federal) · Recurring, next intake TBA
Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration (R33 Clinical Trial Required) United States (federal) · Closes 16 November 2029
Asthma and Allergic Diseases Cooperative Research Centers United States (federal) · Forecast
Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional) United States (federal) · Recurring, next intake TBA
Autism Centers of Excellence P50 United States (federal) · Forecast
Autism Centers of Excellence R01 United States (federal) · Forecast
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) United States (federal) · Closes 25 September 2028
Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed) United States (federal) · Recurring, next intake TBA
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) United States (federal) · Closes 16 November 2027
Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) United States (federal) · Recurring, next intake TBA
Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional) United States (federal) · Recurring, next intake TBA
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) United States (federal) · Closes 7 September 2027
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional) United States (federal) · Closes 5 July 2029
Bioengineering Research, Innovation and Technology Education (BRITE) Program (R25 Clinical Trial Not Allowed) United States (federal) · Forecast
Bioengineering, Biomedical Imaging, and Technology Development - Other Research (OR) (Assistance Listing 93.EB6) United States (federal) · Dates vary
Bioengineering, Biomedical Imaging, and Technology Development - Research Centers (RC) (Assistance Listing 93.EB5) United States (federal) · Dates vary
Bioengineering, Biomedical Imaging, and Technology Development - Research Projects (Assistance Listing 93.EB1) United States (federal) · Dates vary
Bioengineering, Biomedical Imaging, and Technology Development - SBIR/STTR (Assistance Listing 93.EB2) United States (federal) · Dates vary
Bioengineering, Biomedical Imaging, and Technology Development - Training Individual (TR) (Assistance Listing 93.EB3) United States (federal) · Dates vary
Bioengineering, Biomedical Imaging, and Technology Development - Training Institutional (TI) (Assistance Listing 93.EB4) United States (federal) · Dates vary
Biological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed) United States (federal) · Closes 7 May 2029
Biology of Bladder Cancer (R01 Clinical Trial Optional) United States (federal) · Recurring, next intake TBA
Biomarkers of Cognitive Decline and Dementias of Aging in Individuals within the Autism Spectrum United States (federal) · Forecast
Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities United States (federal) · Forecast
Biomedical Research - Institutional Development Award (IDeA) (Assistance Listing 93.GM7) United States (federal) · Dates vary
Biomedical Research - Other Research (OR) (Assistance Listing 93.GM4) United States (federal) · Dates vary
Biomedical Research - Research Centers (RC) (Assistance Listing 93.GM5) United States (federal) · Dates vary
Biomedical Research - Research Projects (RP) (Assistance Listing 93.GM1) United States (federal) · Dates vary
Biomedical Research - SBIR-STTR (SB) (Assistance Listing 93.GM2) United States (federal) · Dates vary
Biomedical Research - Training, Individual (TR) (Assistance Listing 93.GM3) United States (federal) · Dates vary
Biomedical Research - Training, Institutional (TI) (Assistance Listing 93.GM6) United States (federal) · Dates vary
Biomedical Research and Research Training (Assistance Listing 93.859) United States (federal) · Dates vary
Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed) United States (federal) · Closes 27 January 2027
Biomedical Research Facilities (C06 Clinical Trial Not Allowed) United States (federal) · Recurring, next intake TBA
Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed) United States (federal) · Closes 29 January 2029
Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional) United States (federal) · Closes 28 January 2028
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) United States (federal) · Recurring, next intake TBA
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) United States (federal) · Closes 18 August 2027
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development United States (federal) · Forecast
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) United States (federal) · Recurring, next intake TBA
BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE) United States (federal) · Forecast
BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed) United States (federal) · Closes 4 October 2027
BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional) United States (federal) · Recurring, next intake TBA
BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional) United States (federal) · Closes 15 June 2027
BRAIN Initiative: Brain-Behavior Quantification and Synchronization - Transformative Research on Behavior at the Organismal Level United States (federal) · Forecast
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System United States (federal) · Forecast
BRAIN Initiative: Data Archives for the BRAIN Initiative United States (federal) · Forecast
BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional) United States (federal) · Recurring, next intake TBA
BRAIN Initiative: Development and Validation of Novel Tools and New Approaches for Neuroscience Research United States (federal) · Forecast
BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed) United States (federal) · Closes 8 February 2027
BRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed) United States (federal) · Closes 11 February 2027
BRAIN Initiative: Integrative Team-Research BRAIN Circuits Program - iBCP (RM1 Clinical Trial Not Allowed) United States (federal) · Closes 23 June 2028
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed) United States (federal) · Recurring, next intake TBA
BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed) United States (federal) · Recurring, next intake TBA
BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed) United States (federal) · Recurring, next intake TBA
BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed) United States (federal) · Closes 28 January 2027
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access to Broaden Distribution of Enabling Technologies for Neuroscience (U24 Clinical Trial Not Allowed) United States (federal) · Closes 15 June 2027
BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R21 Clinical Trial Optional) United States (federal) · Recurring, next intake TBA
BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R01 Clinical Trial Not Allowed) United States (federal) · Closes 8 February 2029
BRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed) United States (federal) · Closes 6 October 2028
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed) United States (federal) · Closes 8 November 2027
Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (Assistance Listing 93.BZ1) United States (federal) · Dates vary
Bridge2AI Network for AI Health Science United States (federal) · Forecast
Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed) United States (federal) · Recurring, next intake TBA
Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial Optional) United States (federal) · Recurring, next intake TBA
Building Sustainable Software Tools for Open Science (R03 Clinical Trial Not Allowed) United States (federal) · Forecast
Cancer Advancement through Partnerships in Research and Infrastructure (CAPRI) (U54 Clinical Trial Optional) United States (federal) · Closes 25 January 2027
Cancer Biology Research (Assistance Listing 93.396) United States (federal) · Dates vary
Cancer Cause and Prevention Research (Assistance Listing 93.393) United States (federal) · Dates vary
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) United States (federal) · Closes 25 September 2028
Cancer Centers Support Grants (Assistance Listing 93.397) United States (federal) · Dates vary
Cancer Detection and Diagnosis Research (Assistance Listing 93.394) United States (federal) · Dates vary
Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) United States (federal) · Recurring, next intake TBA
Cancer Intervention and Surveillance Modeling Network (CISNET) (U01 Clinical Trial Not Allowed) United States (federal) · Recurring, next intake TBA
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) United States (federal) · Closes 7 January 2027
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) United States (federal) · Closes 25 October 2027
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) United States (federal) · Closes 25 October 2027
Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required) United States (federal) · Recurring, next intake TBA
Cancer Research Manpower (Assistance Listing 93.398) United States (federal) · Dates vary
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) United States (federal) · Recurring, next intake TBA
Cancer Treatment Research (Assistance Listing 93.395) United States (federal) · Dates vary
Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed) United States (federal) · Forecast
CAPSTONE Centers for Multidisciplinary Research in Child Abuse and Neglect United States (federal) · Forecast
Carcinogen Hazard Assessment Monographs Program (CHAMP) (R01 Clinical Trial Not Allowed) United States (federal) · Closes 9 February 2027
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) United States (federal) · Closes 12 November 2027
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required) United States (federal) · Closes 12 November 2027
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed) United States (federal) · Closes 23 December 2027
Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed) United States (federal) · Closes 23 December 2027
Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials United States (federal) · Closes 23 December 2027
Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allow United States (federal) · Closes 23 December 2027
Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed) United States (federal) · Closes 23 December 2027
Causal Hypotheses on the Oral-Systemic Health Impacts of Human Behaviors among People with Chronic Conditions (U01 Clinical Trial Not Allowed) United States (federal) · Closes 5 July 2029
CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed) United States (federal) · Recurring, next intake TBA
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed) United States (federal) · Recurring, next intake TBA
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed) United States (federal) · Recurring, next intake TBA
CCRP Initiative: Promoting a Basic Understanding of Chemical Threats to Skin (R01 Clinical Trial Not Allowed) United States (federal) · Closes 5 November 2028
Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed) United States (federal) · Recurring, next intake TBA
Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed) United States (federal) · Closes 23 November 2026
Cellular Senescence Network (SenNet): SenNet Data Coordination and Integration Center (SenNet DCIC) (UM1 Clinical Trials Not Allowed) United States (federal) · Closes 23 November 2026
Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed) United States (federal) · Closes 23 November 2026
Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed) United States (federal) · Forecast
Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed) United States (federal) · Closes 25 May 2029
Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (P50 Clinical Trial Optional) United States (federal) · Recurring, next intake TBA
Centers for Genomics Research Capacity Building United States (federal) · Forecast
Centers for Research on Neglected Infectious Diseases United States (federal) · Forecast
Centers for Structural Biology of HIV and Other Infectious Diseases (U54 Clinical Trial Not Allowed) United States (federal) · Closes 28 May 2027
Centers of Excellence in Genomic Science (CEGS) United States (federal) · Forecast
Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD) United States (federal) · Forecast
Change of Recipient Organization (Type 7 Parent Clinical Trial Optional) United States (federal) · Closes 12 July 2027
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) United States (federal) · Closes 18 November 2027
Child Health and Human Development Extramural Research (Assistance Listing 93.865) United States (federal) · Dates vary
Child Health and Human Development Extramural Research Projects (Assistance Listing 93.HDR) United States (federal) · Dates vary
Child Health and Human Development Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE) Initiative (Assistance Listing 93.HDM) United States (federal) · Dates vary
Child Health and Human Development Other Research (Assistance Listing 93.HDT) United States (federal) · Dates vary
Child Health and Human Development Research Centers (Assistance Listing 93.HDC) United States (federal) · Dates vary
Child Health and Human Development Research Training - Individual Awards (Assistance Listing 93.HDD) United States (federal) · Dates vary
Child Health and Human Development Research Training - Institutional Awards (Assistance Listing 93.HDN) United States (federal) · Dates vary
Child Health and Human Development Small Business Innovation Research & Small Business Technology Transfer Research (Assistance Listing 93.HDS) United States (federal) · Dates vary
Childhood Asthma in Urban Settings Clinical Research Network United States (federal) · Forecast
Claude D. Pepper Older Americans Independence Centers United States (federal) · Forecast
Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional) United States (federal) · Recurring, next intake TBA
Clinical and Translational Science Award United States (federal) · Forecast
Clinical and Translational Science Award (UM1 Clinical Trial Optional) United States (federal) · Closes 28 September 2027
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) United States (federal) · Closes 7 January 2028
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required) United States (federal) · Closes 2 November 2028
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required) United States (federal) · Recurring, next intake TBA
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required) United States (federal) · Recurring, next intake TBA
Clinical Data Ecosystem for Genomics (CDEG) United States (federal) · Forecast
Clinical Data, Safety and Statistical Centers (CDSSC) United States (federal) · Forecast
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) United States (federal) · Closes 2 November 2026
Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) United States (federal) · Closes 10 November 2026
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed) United States (federal) · Closes 20 July 2028

Showing the first 200. Search the United States catalog for the rest.

See plans

Full eligibility results and funder contacts come with Pro and Lifetime, coming soon.

Information only. GrantSift is not affiliated with any funder. Funder records are built from the official program listings we already carry plus official public sources; anything a source does not publish is left blank. Always confirm details on the funder's own site.